Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Chinese (SSE) Pharma Industry Analysis

UpdatedApr 01, 2026
DataAggregated Company Financials
Companies215
  • 7D4.5%
  • 3M-2.5%
  • 1Y6.0%
  • YTDn/a

Jiangsu Hengrui PharmaceuticalsLtd is up 6.7%, leading the way for the Pharma industry, which has gained 4.5%. This means that the industry has gained 6.0% over the past year. Earnings are forecast to grow by 22% annually.

Industry Valuation and Performance

Has the Chinese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 02 Apr 2026CN¥2.9tCN¥769.7bCN¥68.3b33.1x42.2x3.7x
Sat, 28 Feb 2026CN¥2.9tCN¥766.8bCN¥69.2b34x42.4x3.8x
Mon, 26 Jan 2026CN¥3.0tCN¥765.2bCN¥68.2b35.6x44.6x4x
Wed, 24 Dec 2025CN¥3.0tCN¥766.3bCN¥68.2b33.1x44.4x3.9x
Fri, 21 Nov 2025CN¥3.1tCN¥766.3bCN¥68.2b35.6x45.5x4x
Sun, 19 Oct 2025CN¥3.2tCN¥769.2bCN¥68.0b34.8x46.5x4.1x
Tue, 16 Sep 2025CN¥3.4tCN¥770.4bCN¥66.4b36.4x50.6x4.4x
Thu, 14 Aug 2025CN¥3.3tCN¥780.5bCN¥71.5b37.5x46.1x4.2x
Sat, 12 Jul 2025CN¥2.9tCN¥780.0bCN¥71.3b32x41.3x3.8x
Mon, 09 Jun 2025CN¥2.9tCN¥780.7bCN¥71.5b32.6x40.4x3.7x
Wed, 07 May 2025CN¥2.7tCN¥786.3bCN¥71.8b30.1x36.9x3.4x
Fri, 04 Apr 2025CN¥2.7tCN¥801.4bCN¥78.7b29.8x34.3x3.4x
Sun, 02 Mar 2025CN¥2.5tCN¥800.7bCN¥75.8b28x33.2x3.1x
Tue, 28 Jan 2025CN¥2.5tCN¥800.2bCN¥75.6b27.3x32.6x3.1x
Thu, 26 Dec 2024CN¥2.6tCN¥799.8bCN¥75.6b30.2x34.4x3.3x
Sat, 23 Nov 2024CN¥2.6tCN¥799.8bCN¥75.6b29.6x34.7x3.3x
Mon, 21 Oct 2024CN¥2.6tCN¥799.3bCN¥76.4b28.4x34.4x3.3x
Wed, 18 Sep 2024CN¥2.2tCN¥790.6bCN¥75.8b25.4x29.3x2.8x
Fri, 16 Aug 2024CN¥2.4tCN¥805.8bCN¥76.6b27.7x31x2.9x
Sun, 14 Jul 2024CN¥2.4tCN¥804.8bCN¥76.5b28.2x30.8x2.9x
Tue, 11 Jun 2024CN¥2.5tCN¥805.6bCN¥74.6b27.5x33.9x3.1x
Thu, 09 May 2024CN¥2.8tCN¥821.5bCN¥77.4b32.2x36.3x3.4x
Sat, 06 Apr 2024CN¥2.6tCN¥828.7bCN¥78.3b28.3x33.4x3.2x
Mon, 04 Mar 2024CN¥2.6tCN¥831.7bCN¥80.8b26.3x31.9x3.1x
Wed, 31 Jan 2024CN¥2.4tCN¥831.0bCN¥80.0b25.9x30.4x2.9x
Fri, 29 Dec 2023CN¥2.8tCN¥827.7bCN¥79.7b30x34.9x3.4x
Sun, 26 Nov 2023CN¥2.9tCN¥819.4bCN¥78.7b32.4x37.1x3.6x
Tue, 24 Oct 2023CN¥2.6tCN¥824.6bCN¥78.6b29.5x33.1x3.2x
Thu, 21 Sep 2023CN¥2.7tCN¥824.6bCN¥78.5b31.1x34.8x3.3x
Sat, 19 Aug 2023CN¥2.6tCN¥815.1bCN¥78.1b31.6x33.8x3.2x
Mon, 17 Jul 2023CN¥2.8tCN¥811.0bCN¥76.9b31.1x36.3x3.4x
Wed, 14 Jun 2023CN¥2.8tCN¥809.7bCN¥76.5b32.1x36.9x3.5x
Fri, 12 May 2023CN¥2.9tCN¥808.8bCN¥76.6b32.6x38.2x3.6x
Sun, 09 Apr 2023CN¥3.0tCN¥796.3bCN¥89.8b33.9x33.4x3.8x
Price to Earnings Ratio

33.4x


Total Market Cap: CN¥3.0tTotal Earnings: CN¥89.8bTotal Revenue: CN¥796.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Pharma Industry Price to Earnings3Y Average 37.1x202420252026
Current Industry PE
  • Investors are optimistic on the Chinese Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 42.2x which is higher than its 3-year average PE of 37.1x.
  • The industry is trading close to its 3-year average PS ratio of 3.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 8.7% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Chinese Pharma compare with similar industries?

CN Market0.01%
Healthcare3.60%
Pharma4.50%
Pharma4.50%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
600276 Jiangsu Hengrui PharmaceuticalsLtdCN¥57.736.7%
+CN¥24.0b		13.5%PE49.6x
688506 Sichuan Biokin PharmaceuticalLtdCN¥312.9018.9%
+CN¥20.6b		26.7%PS51.3x
002294 Shenzhen Salubris PharmaceuticalsCN¥66.0515.8%
+CN¥10.0b		95.1%PE109.5x
002821 Asymchem Laboratories (Tianjin)CN¥121.8526.3%
+CN¥9.1b		53.4%PE38.7x
002653 Haisco Pharmaceutical GroupCN¥57.8413.9%
+CN¥7.8b		43.0%PE207.7x

Latest News

000999
CN¥28.41
China Resources Sanjiu Medical & Pharmaceutical
7D
-0.2%
1Y
-15.2%
002294
CN¥66.05
Shenzhen Salubris Pharmaceuticals
7D
15.8%
1Y
95.1%

What Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE:002294) P/E Is Not Telling You

Aug 23
What Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE:002294) P/E Is Not Telling You
605507
CN¥25.87
Guobang Pharma
7D
-2.6%
1Y
22.6%
600566
CN¥26.55
Hubei Jumpcan Pharmaceutical
7D
-0.4%
1Y
-5.2%
301075
CN¥62.89
Tibet Duo Rui Pharmaceutical
7D
-21.9%
1Y
109.0%
600436
CN¥153.00
Zhangzhou Pientzehuang Pharmaceutical
7D
-0.7%
1Y
-24.7%

Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Business Is Yet to Catch Up With Its Share Price

Feb 28
Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Business Is Yet to Catch Up With Its Share Price
002653
CN¥57.84
Haisco Pharmaceutical Group
7D
13.9%
1Y
43.0%
002082
CN¥33.20
Wanbangde Pharmaceutical Holding Group
7D
54.3%
1Y
441.6%
688506
CN¥312.90
Sichuan Biokin PharmaceuticalLtd
7D
18.9%
1Y
26.7%
603139
CN¥26.46
Shaanxi Kanghui Pharmaceutical
7D
-4.5%
1Y
40.9%
301281
CN¥37.21
Shandong Keyuan Pharmaceutical
7D
-19.8%
1Y
13.9%
002821
CN¥121.85
Asymchem Laboratories (Tianjin)
7D
26.3%
1Y
53.4%
600329
CN¥41.65
Tianjin Pharmaceutical Da Ren Tang Group
7D
-4.6%
1Y
33.1%
002422
CN¥36.19
Sichuan Kelun Pharmaceutical
7D
9.1%
1Y
-2.2%
300765
CN¥34.45
CSPC Innovation Pharmaceutical
7D
16.1%
1Y
-14.3%
600276
CN¥57.73
Jiangsu Hengrui PharmaceuticalsLtd
7D
6.7%
1Y
13.5%